The Price of Complementary Health Approaches
Americans spent $30.2 billion on complementary health approaches in a year, according to a recent analysis.
Migraine Patch on Hold for Now
Teva Pharmaceuticals has suspended sales, marketing and distribution for now for the Zecuity (sumatriptan iontophoretic transdermal system) patch.
Got Migraines? Check Your Heart
Women who have been diagnosed with migraines may have a slightly raised risk of heart disease events and heart-related death, a new study found.
FDA Approves Multiple Sclerosis Rx
The US Food and Drug Administration has approved a new treatment for relapsing forms of multiple sclerosis.
Yoga May Go to Your Head
Besides stress reduction, improved flexibility and exercise, yoga may provide another health benefit, a new study found.
Another Danger of Pesticides
Environmental toxins, such as certain pesticides, may be tied to an increased risk for a serious neurodegenerative disease, a new study found.
A Pain Rx That Resists Abuse
The US Food and Drug Administration (FDA) has approved a new opioid with abuse-deterrent properties.
Nuplazid Gets FDA Go-Ahead
The US Food and Drug Administration (FDA) has approved Nuplazid (pimavanserin) tablets to treat hallucinations and delusions in patients with Parkinson's disease.
Top 10 Items For Your Medicine Cabinet
What’s in your medicine cabinet? Did your items make our top 10 list?
Seizure Rx May Cut Dosing in Half
Who wants to take medication twice a day when you can take it once a day?